Andrea Ballagi has nearly 30 years of experience in senior positions within the Life Science industry, with a focus on the commercialization of biotech products, international business development, and sales and marketing. She currently serves as Global Head of Market Development in Oncology at Olink Proteomics AB (now part of Thermo Fisher Scientific). Andrea has previously held several senior roles at Olink, where she built and led commercial teams in Europe and the Asia-Pacific region, as well as at IDEXX Laboratories, where she, among other roles, served as CEO of a Swedish subsidiary.
Andrea Ballagi is a physician, holds a PhD from the Ludwig Institute of Cancer Research in Uppsala, and an MBA from Uppsala University.
